Literature DB >> 2860585

Amelioration of ischaemic brain damage by postischaemic treatment with flunarizine.

J K Deshpande, T Wieloch.   

Abstract

The effect of flunarizine, a calcium entry blocker, on ischaemic damage was investigated using a new model of forebrain ischaemia. Fasted rats were subjected to nine minutes ischaemia and one week recovery. One group served as control; a second was pretreated orally with flunarizine; a third group received postischaemic flunarizine treatment. Focussing on the hippocampus, an area of high susceptibility to ischaemic damage, we report that flunarizine treatment significantly reduced neuronal necrosis. Importantly, the amelioration of necrosis was also observed when flunarizine was administered 5 min following resumption of cerebral perfusion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860585     DOI: 10.1080/01616412.1985.11739696

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

1.  Effects of emopamil on postischemic blood flow and neuronal damage in rat brain.

Authors:  G W Bielenberg; D Sauer; J Nuglisch; T Beck; C Rossberg; H D Mennel; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

2.  An in vitro model of anoxic-induced damage in mouse brain.

Authors:  G E Gibson; V Mykytyn
Journal:  Neurochem Res       Date:  1988-01       Impact factor: 3.996

3.  Selective damage in striatum and hippocampus with in vitro anoxia.

Authors:  G E Gibson; G B Freeman; V Mykytyn
Journal:  Neurochem Res       Date:  1988-04       Impact factor: 3.996

Review 4.  Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

5.  Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbil.

Authors:  B J Alps; C Calder; W K Hass; A D Wilson
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.